You just read:

Theravance Biopharma and Mylan to Present New Data from Studies of YUPELRI™ (revefenacin) at the 2018 CHEST Annual Meeting

News provided by

Theravance Biopharma, Inc. , Mylan N.V.

Oct 08, 2018, 08:30 ET